AVANT Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price.

Business Wire (July 10, 2007)

Permanent Link: http://vlex.com/vid/avant-deficiency-relating-minimum-bid-55947110
Id. vLex: VLEX-55947110

Acceda a este documento
y pruebe vLex GRATIS durante 3 días

Headnotes:

Business
Business, general
Biological products industry
Securities industry
Stock prices
Financial markets

Extract:

AVANT Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price.

NEEDHAM, Mass. -- AVANT Immunotherapeutics (Nasdaq: AVAN) announced today that on July 6, 2007 it received a letter from The NASDAQ Stock Market stating that for the last 30 consecutive business days, the closing bid price per share for AVANT's common stock has b...

Try vLex for FREE for 3 days

Access legal information from United States including:

Constitutions
Forms and Contracts
Legal Books and Journals
Case Law
News and Business
Regulations
U.S. Code

Try vLex without any commitment for 3 days and see why you need it.

days of Free Access

If you are already a vLex customer, Access Here

Sponsored Ads:

Other documents:

Real Decreto 20/2007, de 12 de enero, por el que se designa Embaj... | EDICTE de l Ajuntament de Masarac sobre aprovació definitiva d un projecte d obres. | Arret Cour de cassation Deuxieme Chambre Civile N 68-10634 February 04 1970 | arrete du 26 decembre 2001 portant modification de l arrete du 27 j... | Gemensamma EES-kommitténs beslut nr 49/2003 av den 16 maj 2003 om ändring av bilaga XIII Transport till EES-avtalet | Acórdão Nº 2006/0199940-0 of Superior Tribunal de Justiça Sexta Turma of... | la fiscalía recurre la puesta en libertad de un detenido que robó 30 abrigos de ... | LJN AF0181 Rechtbank s-Hertogenbosch 99/31 R | Acuerdo Nº 212494900 of 8ª Câmara de Direito Privado | acórdão nº 81033 of primeira turma, of october 05, 2001 | LJN: AU5632, Hoge Raad, 00813/05

AVANT Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price.

Sponsored Ads:

Headnotes:

Extract:

Sponsored Ads:

News and Business